Employers test subsidized GLP-1 access through eMed and CVS Caremark

Telehealth company eMed is partnering with CVS Caremark to let employers offer GLP-1 obesity meds to workers via online prescriptions with comprehensive weight-management support; employers can subsidize the drugs to varying degrees, with prices touted as the market’s most cost-effective option. Aon piloted a similar program for its staff, and CVS sees the move as expanding access through its PBM network for up to 30 million Americans. The program combines online cash purchases with secondary coverage to help keep workplace health costs in check, backed by continuous clinical support and monitoring to improve adherence and outcomes.